Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intercept Pharmaceuticals
(NQ:
ICPT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
18.92 (39)
Ask (Size)
19.02 (1,075)
Prev. Close
19.00
Today's Range
N/A - N/A
52wk Range
18.91 - 19.02
Shares Outstanding
41,782,727
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
February 13, 2024
Gilead's acquisition of CymaBay Therapeutics for $4.3 billion strengthens its liver disease portfolio. Analysts see potential in seladelpar's impact on PBC and pruritus, projecting peak sales of $800...
Via
Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
October 26, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Performance
More News
Read More
Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now
October 19, 2023
Via
InvestorPlace
INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
October 16, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Analyst Expectations for Intercept Pharma's Future
September 27, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
October 03, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
September 27, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
Why Intercept Pharmaceuticals Stock Is Skyrocketing Today
September 26, 2023
Via
The Motley Fool
Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?
September 26, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 26, 2023
Via
Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
September 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) is a Leading Gainer in Tuesday Morning Trading
September 26, 2023
Via
Investor Brand Network
Dow Tumbles 150 Points; US House Prices Rise in July
September 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today?
September 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 26, 2023
Via
Benzinga
ICPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders
September 26, 2023
From
Halper Sadeh LLC
Via
Business Wire
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 22, 2023
Via
Benzinga
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
September 21, 2023
Via
Benzinga
Why CymaBay Therapeutics Stock Is Jumping Today
September 08, 2023
Via
The Motley Fool
Why CymaBay, With 172% Growth This Year, Just Surged For A Second Day Running
September 08, 2023
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
